Management of Cardiovascular Disease in Kidney Disease (MaCK) Study

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions

Chronic Kidney DiseaseCardiovascular DiseaseInflammationAtherosclerosisAortic Stiffness

Interventions

PROCEDURE

MRI carotid

To assess the carotid atherosclerotic plaques

PROCEDURE

APWV

Doppler measurement of the APWV

DRUG

Hydroxychloroquine

Active Drug

DRUG

Matching Placebo

Matching Placebo for the control group.

Trial Locations (1)

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville

All Listed Sponsors

lead

VA Office of Research and Development

FED

NCT03636152 - Management of Cardiovascular Disease in Kidney Disease (MaCK) Study | Biotech Hunter | Biotech Hunter